Assessing the effect of ondansetron on peripheral vertigo

Comparative study of the effectiveness of promethazine with ondansetron in patients with acute peripheral vertigo

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180129038543N1

Enrollment

170

Registered

2018-03-14

Start date

2017-10-24

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute peripheral vertigo. Disorders of vestibular function

Interventions

Intervention 1: First intervention group: promethazine 25 mg muscular and 1 cc distilled water injected intravenously.before injection and after 30 minutes and 2 hours of drug administration patients

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having acute peripheral vertigo Symptoms of vertigo include severe dizziness, attack with and without severe nausea age between 20-60 years

Exclusion criteria

Exclusion criteria: New associated neurological symptoms

Design outcomes

Primary

Measure	Time frame
Vertigo score in the questionnaire. Timepoint: Before injection; 30 minutes later and 2 hours after prescribing. Method of measurement: visual analogue scale, reliefe score,questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Sutohian

Rasht University of Medical Sciences

ssutohian@gmail.com+98 13 3377 5940

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026